To further characterize altered expression of TCRzeta , p56 ( lck ) , and impaired activation of NFkappaB , T lymphocytes were obtained from 65 patients with RCC , the majority of whom were receiving combination cytokine therapy [ interleukin ( IL ) -2 , IFN alpha -containing regimens ] and 37 control individuals .
to further characterize altered expression of tcrzeta , p56 ( lck ) , and impaired activation of nfkappab , t lymphocytes were obtained from 65 patients with rcc , the majority of whom were receiving combination cytokine therapy [ interleukin ( il ) -2 , ifn alpha -containing regimens ] and 37 control individuals .
O O O O O O B-protein_molecule O B-protein_molecule I-protein_molecule I-protein_molecule I-protein_molecule O O O O O B-protein_complex O B-cell_type I-cell_type O O O O B-multi_cell O B-other_name O O O O O O O O B-protein_family_or_group O O B-protein_molecule I-protein_molecule I-protein_molecule I-protein_molecule I-protein_molecule O B-protein_molecule I-protein_molecule O O O O O O O O